Reduction of Edema and Infarction by Memantine and MK-801 Af...
Gorgulu A, Kins T, Cobanoglu S, Unal F, Izgi N I, Yanik B and Kucuk M

High-Dose Albumin Treatment for Acute Ischaemic Stroke (ALIA...
Ginsberg MD, Palesch Y Y, Hill M D, Martin R H, Moy C S, Barsan W G, Waldman B D, Tamariz D and Ryckborst K J

Neuroprotection for Ischemic Stroke: Past, Present and Futur...
Ginsberg MD

Pharmacologic Preconditioning: Translating the Promise
Gidday JM

Novel Stroke Therapeutics: Unraveling Stroke Pathophysiology...
George PM and Steinberg G K

Stroke Treatment--Light at the End of the Tunnel?
Garber K

A Comparison of Hyperbaric Oxygen Versus Hypoxic Cerebral Pr...
Freiberger JJ, Suliman H B, Sheng H, McAdoo J, Piantadosi C A and Warner D S

Defining Toxicological Tipping Points in Neuronal Network De...
Frank CL, Brown J P, Wallace K, Wambaugh J F, Shah I and Shafer T J

The Cost of Cerebral Ischaemia
Flynn RW, MacWalter R S and Doney A S

Missing steps in the STAIR case: a Translational Medicine pe...
Feuerstein GZ, Zaleska M M, Krams M, Wang X, Day M, Rutkowski J L, Finklestein S P, Pangalos M N, Poole M, Stiles G L, Ruffolo R R and Walsh F L

International, Multicenter Randomized Preclinical Trials in ...
Dirnagl U and Fisher M

Found in Translation: Preclinical Stroke Research Predicts H...
Dirnagl U and Endres M

Bench to Bedside: the Quest for Quality in Experimental Stro...
Dirnagl U

Thomas Willis Lecture: Is Translational Stroke Research Brok...
Dirnagl U

Glucose but Not Lactate in Combination With Acidosis Aggrava...
Cronberg T, Rytter A, Asztely F, Soder A and Wieloch T